Latest News

Successful IPO with MedUni Vienna patent

Swedish company Cyxone, a subsidiary of ACCEQUA AB, headquartered in Malmö, recently went public – on the basis of a MedUni Vienna patent application relating to the potential development of an oral medication to combat multiple sclerosis. The invention “Cyclotides as immunosuppressive agents ” is the work of Christian Gruber from the Center for Physiology […]

Read More

Multiple sclerosis: Plant peptide could prevent onset of the disease

https://www.sciencedaily.com/releases/2016/03/160329101244.htm

Read More

Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis

http://www.pnas.org/content/early/2016/03/22/1519960113.full.pdf http://tvthek.orf.at/program/ZIB-1/1203/ZIB-1/12317916/Hoffnung-fuer-Multiple-Sklerose-Patienten/12318077

Read More